MaxCyte, Inc. (MXCT)
1.35
+0.04
(+3.05%)
USD |
NASDAQ |
Nov 06, 10:19
MaxCyte Profit Margin (Quarterly) : -122.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -122.0% |
| March 31, 2026 | -49.22% |
| December 31, 2025 | -131.5% |
| September 30, 2025 | -181.8% |
| June 30, 2025 | -145.3% |
| March 31, 2025 | -98.76% |
| December 31, 2024 | -121.9% |
| September 30, 2024 | -141.6% |
| June 30, 2024 | -89.89% |
| March 31, 2024 | -83.99% |
| December 31, 2023 | -33.68% |
| Date | Value |
|---|---|
| September 30, 2023 | -140.6% |
| June 30, 2023 | -116.2% |
| March 31, 2023 | -126.9% |
| December 31, 2022 | -38.71% |
| September 30, 2022 | -60.45% |
| June 30, 2022 | -85.97% |
| March 31, 2022 | -35.10% |
| December 31, 2021 | -48.01% |
| September 30, 2021 | -26.44% |
| June 30, 2021 | -62.21% |
| March 31, 2021 | -109.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 19.28% |
| Bio-Rad Laboratories, Inc. | 57.05% |
| Bruker Corp. | -12.55% |
| Azenta, Inc. | -0.95% |
| Danaher Corp. | 18.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.50% |
| Return on Assets | -17.56% |
| Return on Invested Capital | -18.59% |
| Gross Profit Margin (Quarterly) | 63.86% |
| Operating Margin (Quarterly) | -111.2% |
| Return on Net Operating Assets | -82.21% |